Sangamo Biosciences (NASDAQ: SGMO) announced unanimous approval by the National Institutes of Health's Recombinant DNA Advisory Committee (RAC) of a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE